The invention discloses a method for preparing a PDGF (platelet derived growth factor) acceptor inhibitor through solid-phase synthesis. The polypeptide is composed of 47 amino acids and is used to treatment on tumors, hepatic fibrosis and other diseases. The technical scheme comprises the following steps: taking 2-chlorotrityl chloride resin or wang resin with the substitution degree of 0.2 mmol/g-0.9 mmol/g as an initial raw material, and successively connecting protective amino acids according to the amino acid sequence of the polypeptide from the C terminal by using a solid-phase synthesis process; on the aspect of synthetic strategy, employing a special amino acid to enclose an active site, using a protection group with relatively large steric hindrance to process the side chain of a protective amino acid at a specific position so as to destroy beta-sheet in the peptide chain, and using other special synthetic manners; after synthesis is finished, cutting the synthesized polypeptide from resin by using a cutting fluid, and simultaneously cutting off the side-chain protection group of amino acids, and performing ether precipitation and washing, so as to obtain a high-purity polypeptide crude product. Through HPLC detection, the purity of the target polypeptide reaches 62.5% or more. The related synthetic method has the advantages of stable technology, reliable raw material source, high synthetic efficiency, stable product quality, low synthesis cost and simple operation, and is suitable for large-scale production.